Professor Aaron SulkesHead of the Oncology Center
In one of the most modern and globally recognized clinics in Israel, the Tel Aviv Sourasky Medical Center, cancer treatment is conducted using all available, cutting-edge methods. Cancer is the disease of the century, the most frightening illness that causes suffering and threatens the patient's life.
In various countries, cancer patients are considered hopeless cases, treated with outdated methods that yield minimal results.
Israel is strikingly different from many countries around the world; here, patients who are considered "incurable" at home are treated and, importantly, cured. All medical institutions in Israel not only treat cancer patients but also restore health and hope. The Top Ichilov clinic has been diagnosing and treating patients suffering from cancer for many years.
One of the modern and effective methods of cancer treatment at the Top Ichilov clinic is biological therapy.
This method is based on the impact of specific medical drugs on cancerous tissues. The drugs are applied based on genetic analysis of the pathological process when the tumor is just beginning to develop or is in a state of metastasis, and they affect the focus at the cellular level.
Oncologists have discovered protein drugs that create a block in the receptors responsible for receiving signals for the development of malignant processes and triggering the mechanism of malignant transformation of healthy cells. They are called tumor markers.
Individual tumor markers are determined for various types of cancer. Medications designed for the treatment of a specific type of cancer are developed for specific tumor markers. The Top Ichilov clinic uses the following drugs:
- "Arbitox" – a drug for treating colon tumors in advanced, metastatic cancer. "Arbitox" is prescribed if normal KRASS protein is detected in the tumor cells. In this case, the drug shows effectiveness in more than 70% of patients. Moreover, 35% of patients manage to reduce the tumor volume to operable size. If altered KRASS is detected in the tumor cells, "Arbitox" is contraindicated, as it does not affect the progression of the pathological process. According to statistics, the mutating KRASS occurs in less than 40% of patients suffering from colorectal cancer.
- "Vemurafenib" - is a drug that inhibits the production of the BRAF gene. The BRAF gene is found in 70% of patients suffering from melanoma. In other cases, this mutation is absent. The use of "Vemurafenib" is indicated only in the presence of BRAF; other patients are prescribed the most effective treatment for them.
- "Herceptin" - effectively acts on breast cancer when the tumor cells express the HER-2 tumor marker. In cases where this tumor marker is not detected, patients are indicated for treatment by other means.
- "Gefitinib" - the most effective drug for treating adenocarcinomatous lung cancer, used in combination with chemotherapy. The drug is indicated in most cases for non-smoking patients with mutations in EGFR and ALK proteins.
Biological treatment of malignant diseases is currently the most promising and modern method. It relies on genetic research and tumor analyses. At the Top Ichilov clinic, testing for tumor markers is part of the mandatory diagnostic examination program for patients. This method provides extensive opportunities for treating patients according to individual schemes, significantly increasing positive outcomes.
To receive a free consultation with specialists at the Top Ichilov clinic regarding biological methods of cancer treatment, fill out a treatment request right now
- Vipoma
- Leukemia
- Treatment of glioblastoma
- Treatment of vaginal cancer in Israel
- Hodgkin's lymphoma
- Bone metastases
- Myeloma
- Neurofibroma
- Throat cancer
- Breast cancer
- Intestinal cancer
- Blood cancer
- Facial cancer
- Bladder cancer
- Ureter cancer
- Adrenal cancer
- Liver cancer
- Penis cancer
- Oral cavity cancer
- Thymus cancer
- Ear cancer
- Thyroid cancer
- Sarcoma
- Thymoma